Evidence map›Paper›PMID 39150249›Full record

ArticleMicrobiology spectrum2024

Discovery of clinical isolation of drug-resistant

Ping Tian, Ming-Juan Guo, Qing-Qing Li, Xu-Feng Li, Xiao-Qiang Liu, Qin-Xiang Kong, Hui Zhang, Yi Yang, Yan-Yan Liu, Liang Yu and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. From computational screening toFrontiers in microbiology · 2026
    Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Ping Tian *Department of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Hefei, China.ORCID 0009-0005-5887-4266
Ming-Juan Guo *Department of Hepatology, The First Affiliated Hospital of Jilin University, Changchun, China.
Qing-Qing LiDepartment of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Xu-Feng LiDepartment of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Xiao-Qiang LiuDepartment of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Qin-Xiang KongDepartment of Infectious Diseases, Chaohu Hospital of Anhui Medical University, Hefei, China.
Hui ZhangDepartment of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Yi YangDepartment of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Yan-Yan LiuDepartment of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Liang YuDepartment of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Jia-Bin LiDepartment of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Hefei, China.ORCID 0000-0002-6539-1802
Ya-Sheng LiDepartment of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Hefei, China.ORCID 0009-0002-5703-6445

Funding

China Postdoctoral Science Foundation (China Postdoctoral Foundation Project)Foundation for Innovative Research Groups of the National Natural Science Foundation of China
6 · The paper itself

Abstract

Background emergence of multidrug-resistant (MDR) bacterial strains is a public health concern that threatens global and regional security. Efflux pump-overexpressing MDR strains from clinical isolates are the best subjects for studying the mechanisms of MDR caused by bacterial efflux pumps. A

Indexed as

Anti-Bacterial AgentsBacterial ProteinsCiprofloxacinDrug Resistance, Multiple, BacterialKlebsiella InfectionsKlebsiella pneumoniaeMembrane Transport ProteinsMicrobial Sensitivity TestsHumansLevofloxacinAnti-Bacterial AgentsBacterial ProteinsCiprofloxacinLevofloxacinMembrane Transport Proteinsefflux pumpKlebsiella pneumoniaeOqxBPaβNquinolones-resistant

Identifiers

PMID39150249
PMCPMC11448435

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.